Charité Berlin, Campus Benjamin Franklin

Berlin 12203

0 studies enrolling now · 3 studies all time

What they study most

Coronary Artery Disease, Immune Thrombocytopenic Purpura, NYHA Class III Heart Failure, NYHA Class IV Heart Failure

Studies at this site

• Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C — Completed
• A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) — Completed
• Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting — Status unconfirmed